PeƱaflor, Elizabeth C.

HRN: 04-54-98  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
CEFTAZIDIME 1GM (VIAL)
07/09/2023
07/15/2023
IVT
1g
Q8
CAP MR
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: